Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT05328908
Brief Title: A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer (RELATIVITY-123)

First Submitted : March 14, 2022
First Submitted that Met QC Criteria : April 13, 2022
First Posted : April 14, 2022

Last Update Submitted that Met QC Criteria : July 28, 2022
Last Update Posted : July 29, 2022